During the past decade, Kindai University Hospital conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 11 clinical trials were completed, i.e. on average, 22% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 9 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kindai University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 10 trials, followed by "Daiichi Sankyo, Inc." with 8 trials sponsored, "Celgene" with 7 trials sponsored, "Loxo Oncology, Inc." with 5 trials sponsored and "Haruhiko Fukuda" with 5 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kindai University Hospital" #1 collaborator was "AstraZeneca" with 6 trials as a collaborator, "Ministry of Health, Labour and Welfare, Japan" with 6 trials as a collaborator, "Eli Lilly and Company" with 5 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator and "Japan Lung Cancer Society" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Kindai University Hospital" are "Non-Small Cell Lung Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Myelodysplastic Syndromes" (3 trials), "Non-small Cell Lung Cancer" (3 trials) and "Advanced Hepatocellular Carcinoma" (2 trials). Many other conditions were trialed in "Kindai University Hospital" in a lesser frequency.

Most popular intervention types in "Kindai University Hospital" are "Drug" (57 trials), "Other" (5 trials), "Procedure" (5 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Apalutamide" (3 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kindai University Hospital" are 53 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Kindai University Hospital". undefined are not yet recruiting, 26 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Kindai University Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Kindai University Hospital, 5 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".